EUVIMEDEUVIMED entdecken
Crossref

The negative spillover impact of the COVID-19 pandemic on Hong Kong diabetes patients’ mortality and cardiovascular disease

Zhuoran Hu, Hin Moi Youn, Qiao Jin, Jianchao Quan, Cindy, Lo Kuen Lam, Eric, Yuk Fai Wan

British Journal of General Practice · 2024

DOI: 10.3399/bjgp24x738045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of General Practice, 2024. Verfasst von Zhuoran Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: The University of Hong Kong. Hauptthemen laut MEDLINE: COVID-19, Cardiovascular Diseases, Diabetes Mellitus, SARS-CoV-2. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The spillover impact from disrupted healthcare services for non-COVID-infected diabetes mellitus (DM) patients caused by the reshuffling of the manpower during the pandemic remains understudied, especially in Hong Kong where healthcare resources were already strained before the pandemic.

Aim

To evaluate the spill-over effect of the Pandemic on Hong Kong diabetes patients, we examined the change in all-cause mortality and the incidence of cardiovascular disease (CVD) from 2012 to 2021.

Method

This retrospective cohort study analyzed data from Hong Kong Hospital Authority healthcare records covering all publicly provided care. Adults diagnosed with DM on/before December 31, 2010, without CVD before January 2012 were included. The 2016–2019 average all-cause mortality and the incidence of CVD after age-standardization represented the pre-pandemic levels. Subjects would leave the cohort after being infected with COVID-19.

Results

A cohort of 159,693 patients with diabetes was identified and followed up for 10 years from January 2012 to December 2021. Compared to the pre-pandemic levels, 2020 saw a 12% increase in age-standardized mortality per 10,000 diabetic patients (incidence rate ratio [95% CI]: 1.12 [1.10 - 1.14]), but no significant change in age-standardized CVD incidence. However, in 2021, there were 11% (1.11[1.10 - 1.13]) and 13% (1.13 [1.11 - 1.15]) more new CVD cases and deaths, respectively, versus the pre-pandemic period.

Conclusion

The COVID-19 outbreak in 2020 had negative spillover impacts on DM patients without COVID-19 in Hong Kong, with a higher mortality in 2020 and 2021 compared with the pre-pandemic level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Cardiovascular DiseasesDiabetes MellitusSARS-CoV-2HumansHong KongMaleFemaleRetrospective StudiesMiddle AgedAgedIncidenceAdultPandemicsCause of Death

Autor:innen und Institutionen

  • The University of Hong Kong.

Zitieren

APA

Hu, Z., Youn, H. M., Jin, Q., Quan, J., Cindy, Lam, L. K., Eric, & Wan, Y. F. (2024). The negative spillover impact of the COVID-19 pandemic on Hong Kong diabetes patients’ mortality and cardiovascular disease. British Journal of General Practice. https://doi.org/10.3399/bjgp24x738045

Vancouver

Hu Z, Youn HM, Jin Q, Quan J, Cindy, Lam LK, et al. The negative spillover impact of the COVID-19 pandemic on Hong Kong diabetes patients’ mortality and cardiovascular disease. British Journal of General Practice. 2024. doi:10.3399/bjgp24x738045

BibTeX
@article{Hu2024,
  author = {Hu, Zhuoran and Youn, Hin Moi and Jin, Qiao and Quan, Jianchao and Cindy and Lam, Lo Kuen and Eric and Wan, Yuk Fai},
  title = {The negative spillover impact of the COVID-19 pandemic on Hong Kong diabetes patients’ mortality and cardiovascular disease},
  journal = {British Journal of General Practice},
  year = {2024},
  doi = {10.3399/bjgp24x738045}
}
Kostenlos starten →